Christian Heidbreder, Chief Scientific Officer at Indivior Pharmaceuticals, sold INDV on Jul 10, 2026
Data as of Oct 16
▼ SELL$765K18,586 shares at $41.14Christian Heidbreder Chief Scientific OfficerINDV Indivior Pharmaceuticals, Inc.
- Traded
- Jul 10, 2026
- Disclosed
- Jul 13, 2026
- Filed
- 3 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
INDV since disclosure
−19.3%
after the sale
Similar stocks (XLV) since disclosure
+9.5%
XLV — its sector index fund
Change in closing price from Jul 13, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.